Myomo (MYO) EPS (Weighted Average and Diluted) (2021 - 2025)
Myomo (MYO) reported EPS (Weighted Average and Diluted) of -$0.09 for Q3 2025, down 200.0% on a YoY basis from $0.09 in Q3 2024, and up 18.18% quarter-over-quarter from -$0.11 in Q2 2025.
Myomo (MYO) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Myomo has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at -$0.09 in Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 200.0% year-over-year to -$0.09; the trailing twelve-month figure through Sep 2025 stood at -$0.28 (down 21.74% YoY), and the FY2024 full-year result was -$0.16, up 42.86% from the prior year.
- EPS (Weighted Average and Diluted) for Q3 2025 stood at -$0.09, up from -$0.11 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.17 in Q4 2024, with the low at -$0.51 in Q4 2021.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.19 across 5 years, with a median of -$0.11 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) surged 348.37% — and 2025, when it plunged 266.67%.
- Myomo's EPS (Weighted Average and Diluted) stood at -$0.51 in 2021, then soared by 45.1% to -$0.28 in 2022, then soared by 75.0% to -$0.07 in 2023, then surged by 348.37% to $0.17 in 2024, then slumped by 151.77% to -$0.09 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.09 (Q3 2025), -$0.11 (Q2 2025), and -$0.08 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Myomo | 49.44 Mn | 31.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | -0.08 |
| Dec 31, 2024 | 0.17 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.10 |
| Dec 31, 2023 | -0.07 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.11 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | -0.41 |
| Dec 31, 2021 | -0.51 |
| Sep 30, 2021 | -0.36 |
| Jun 30, 2021 | -0.46 |